Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
Jianglin Zheng, Zijie Zhou, Yue Qiu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance
Tianqi Liu, Chen Zhu, Xin Chen, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 7, pp. 1113-1125
Open Access | Times Cited: 138
Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Amar Balihodzic, Felix Prinz, Michael A. Dengler, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1094-1106
Open Access | Times Cited: 98
Targeting stearoyl-coa desaturase enhances radiation induced ferroptosis and immunogenic cell death in esophageal squamous cell carcinoma
Hui Luo, Xiaohui Wang, Shuai Song, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1
Jianglin Zheng, Qing Zhang, Zhen Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 32
A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients
Yikang He, Yangfan Ye, Wei Tian, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 34
A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma
Fada Xia, Yuanliang Yan, Cong Shen
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 34
Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment
Izadora de Souza, Maria Carolina Clares Ramalho, Camila Banca Guedes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6879-6879
Open Access | Times Cited: 26
5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
Jiheng Zhang, Nan Wang, Jiasheng Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
Yao jun Li, Hai Yan Li, Quan Zhang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 22
Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy
Dakun Pei, Dandan Zhang, Yan Guo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 694-694
Open Access
Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
Xiajing Liu, Wenwei Cheng, Heqing Li, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
LncRNA as potential biomarker and therapeutic target in glioma
Xun Xu, Yuan Liang, Ilgiz Gareev, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 1, pp. 841-851
Closed Access | Times Cited: 14
Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
Lincheng Ju, Yaxing Shi, Gang Liu
PeerJ (2022) Vol. 10, pp. e14506-e14506
Open Access | Times Cited: 14
LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2
Zhining Yang, Zhaoyong Liu, Weiqing Lu, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 9
Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
Marc Dahlmanns, Eduard Yakubov, Jana Katharina Dahlmanns
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19
The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer
Rui Geng, Tian Chen, Zihang Zhong, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4056-4056
Open Access | Times Cited: 14
Protein arginine methyltransferase 8 regulates ferroptosis and macrophage polarization in spinal cord injury via glial cell‐derived neurotrophic factor
Zehua Zou, Ruixuan Liu, Yiwen Wang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2145-2161
Open Access | Times Cited: 7
Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
Chengyin Weng, Lina Wang, Guolong Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
Yujian Xu, Youbai Chen, Zehao Niu, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 12
Learning curve for robotic thyroidectomy using BABA: CUSUM analysis of a single surgeon’s experience
Hui Ouyang, Wenbo Xue, Zeyu Zhang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12
Amplifying T cell‐mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti‐PD1
Beilei Gong, Liping Wang, Han Zhang, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 2
Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma
Shuang Liang, Lanting Ji, Zhenyuan Yu, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 2
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements
Xifeng Fei, Jie Wu, Haiyan Tian, et al.
Cancer Biomarkers (2024) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 2
Targeting ferroptosis opens new avenues in gliomas
Yuxin Wei, Yang Xu, Qian Sun, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4674-4690
Open Access | Times Cited: 2
Regulators of epigenetic change in ferroptosis‑associated cancer (Review)
Jiaming Wu, Shuang Zhu, Peng Wang, et al.
Oncology Reports (2022) Vol. 48, Iss. 6
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top